Former Executive Vice President, Chief Financial Officer · Sana Biotechnology, Inc. (SANA)

Nathan Hardy

A named executive officer of Sana Biotechnology in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$3,050,230

Salary $390,283Stock awards $642,655

FY2023: $1,185,767

2nd of 4 named executive officers at Sana Biotechnology by FY2024 total.

4 named officers on file for Sana Biotechnology, FY2024

Nathan Hardy’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Sana Biotechnology’s whole pay program stands against its peers

  • Sana Biotechnology’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SANA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Nathan Hardy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Nathan Hardy compensation by year

Sana Biotechnology Summary Compensation Table · all 3 fiscal years held
In US dollars, as Sana Biotechnology reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2023FY2024
Salary$413,493$468,921$390,283
Bonus$100,000$0$0
Stock awards$0$30,800$642,655
Option awards$0$501,923$1,965,206
Non-equity incentive$170,000$180,123$0
Pension and deferred compensation$0$0$0
All other$0$4,000$52,086
Total$683,493$1,185,767$3,050,230

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sana Biotechnology, Inc. DEF 14A filed April 25, 2025, accession 0001193125-25-094656, and prior-year filings.

How this page was built: the Sana Biotechnology, Inc. filed document, accession 0001193125-25-094656. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

$683K
$1.2M
$3.1M
FY21
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Sana Biotechnology’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Steven HarrPresident, Chief Executive Officer, and Director$8,788,580
Nathan Hardy · this pageFormer Executive Vice President, Chief Financial Officer$3,050,230
Douglas WilliamsFormer Executive Vice President and President, Research and Development$2,754,070
Bernard CassidyExecutive Vice President, General Counsel, and Corporate Secretary$2,345,597

The full Sana Biotechnology compensation record

free company brief

This page is one person within Sana Biotechnology's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sana Biotechnology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nathan Hardy's compensation dossier · One-time report. No refunds.